Categories
Pharmaceutical

Why is the U.S Experiencing High Demand for Lung Cancer Treatment – Exclusive Report by Fact.MR

250 Pages Lung Cancer Treatment Market Survey by Fact MR, A Leading Business and Competitive Intelligence Provider

According to Fact MR’s recent market research, sales of Lung Cancer Treatment to swell at propelled CAGR through 2031, as investment towards expansion of healthcare infrastructure continues rising. The goal of the survey is uncover growth opportunities, key trends, growth drivers, and challenges. It also provides recommendations to assist businesses in preparing for unforeseen challenges.

Focus on improving overall patient care will remain a chief growth driver. Besides this, Lung Cancer Treatment market will continue gaining from increasing willingness among patients and families to spend on advanced healthcare.

To remain ‘ahead’ of your competitors, request for a sample – https://www.factmr.com/connectus/sample?flag=S&rep_id=49 

A newly published report by Fact.MR estimates the global Lung Cancer Treatment market revenue to reach US$ 4 Bn by 2031, representing a 2x increase from 2020. Augmented development of lung cancer-specific biomarkers is propelling demand for the Lung Cancer Treatment over the forecast period. Revenue from CA tests will account for US$ 1 Bn by 2031-end.

The market study done by Fact.MR gives exclusive information about how the market will grow. The study identifies crucial trends that are determining the growth of Lung Cancer Treatment market. This newly published report sheds light on vital dynamics, such as the drivers, restraints, and opportunities for key market players as well as emerging players associated with the production and supply. The latest report by Fact.MR provides detailed Market Analysis of Lung Cancer Treatment

The report offers actionable and valuable market insights of Lung Cancer Treatment. The latest report by Fact.MR provides details on the present scenario of the market across various regions along with the historic data and forecast of the market. The report also includes information on the sales and demand of Lung Cancer Treatment Market across various industries and regions.

This newly published and insightful report sheds light on Market Insights of Lung Cancer Treatment, key dynamics, their impact on the overall value chain from suppliers to end-users and Growth of Lung Cancer Treatment Market.

Need more information about Report Methodology? Click here- https://www.factmr.com/connectus/sample?flag=RM&rep_id=49 

Segmentation:

  • Test Type

    • CA Test for Lung Cancer Treatment
    • HER2 Tests for Lung Cancer Treatment
    • ALK Tests for Lung Cancer Treatment
    • Angiogenesis Inhibitor for Lung Cancer Treatment
    • EGFR Mutation Tests for Lung Cancer Treatment
    • KRAS Mutation Tests for Lung Cancer Treatment
    • Others
  • End-User

    • Lung Cancer Treatment  for Hospital Associated Labs
    • Lung Cancer Treatment for Independent Diagnostic Laboratories
    • Lung Cancer Treatment for Cancer Research Institutes
    • Others
  • Indication

    • Non-Small-cell Lung Cancer Treatment
    • Small-cell Lung Cancer Treatment

Full Access of this Exclusive Report is Available at- https://www.factmr.com/checkout/49 

Key Takeaways from Market Study

  • By test type, CA lung cancer diagnostic tests to reign supreme, clocking US$ 1 Bn by 2031
  • Hospital-associated labs set to reach around US$ 1.6 Bn until 2031
  • Treatment for non-small cell lung cancer (NSCLC) to comprise over 50% of total demand
  • Cancer research institutes to make significant use of Lung Cancer Treatment, expanding at 6% CAGR
  • Angiogenesis inhibitors is the fastest growing segment followed by HER2 tests
  • U.S to acquire around 27% market share in the global Lung Cancer Treatment industry
  • China is expected to register a CAGR of around 8% until 2031, with NSCLC treatment gaining traction

“Rapid technological advancements with respect to human diagnostics is prompting Lung Cancer Treatment service providers to leverage key advancements, including AI and automation, opening lucrative growth frontiers,” comments a Fact.MR analyst.

Competitive Landscape

Prominent players are embracing innovative approaches such as ground-breaking marketing tactics, technological advances for cancer screening, mergers, and acquisitions.

  • In March 2021, Next-generation sequencing (NGS)-based precision oncology provider Geneseeq Technology Inc. collaborated with Illumina, Inc. (to develop comprehensive in-vitro diagnostic (IVD) NGS testing kits for cancer, using Illumina’s NextSeq™ 550Dx sequencing platform.
  • In Jan 2017, Abbott Laboratories completed largest the acquisition of St.Jude Medical for US$ 25 Bn. Together, the company will compete in nearly every area of the $30 billion cardiovascular markets and hold the No. 1 or 2 positions across large and high-growth cardiovascular device markets.

Read More Trending Reports of Fact.MR- https://www.biospace.com/article/demand-for-tricuspid-valve-repair-rising-as-congenital-and-rheumatoid-heart-disease-cases-increase-fact-mr/

Report Benefits & Key Questions Answered

  • Lung Cancer Treatment Category and segment level analysis: Fact MR provides a detailed analysis of the factors influencing sales growth across key segments. It highlights key growth drivers and provides useful information for identifying sales prospects at the regional and local level.
  • Lung Cancer Treatment Historical volume analysis: The report provides a comparison of Lung Cancer Treatment’s historical sales and projected sales performance for 2021-2031.
  • Lung Cancer Treatment Manufacturing trend analysis: The report offers a detailed analysis of manufacturing trends in the Lung Cancer Treatment market. It carefully gauges the impact of changing healthcare needs of key demographics globally
  • Lung Cancer Treatment Consumption by demographics: The report investigates consumer behavior affecting Lung Cancer Treatment demand outlook for the assessment period. Effect of their keenness for digital trends on Lung Cancer Treatment market is carefully analyzed
  • Post COVID consumer spending on Lung Cancer Treatment: Healthcare industry has been largely influenced by COVID-19 pandemic. The Fact MR Market survey analyzed consumer spending post COVID-19. It assesses how current trends that will influence expenditure on healthcare services, thus affecting Lung Cancer Treatment market growth.

More Valuable Insights on Lung Cancer Treatment Market

Fact.MR, in its new report, offers an unbiased Market Analysis of Lung Cancer Treatment, Sales and Demand of Lung Cancer Treatment, analyzing forecast statistics through 2019 and beyond. The study reveals growth projections on the basis of various criteria.

Explore Fact.MR’s Comprehensive Coverage on Healthcare Domain:

Fluoro Enzymatic Assays Market – Global Industry Analysis and Opportunity Assessment 2021 – 2031

Shower Chairs Market – Global Industry Analysis and Opportunity Assessment 2021 – 2031

Infrared Thermometer Market – Global Industry Analysis and Opportunity Assessment 2021 – 2031

About Fact.MR

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. We have offices in US and Dublin, whereas our global headquarter is in Dubai. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Reach out to us with your goals, and we’ll be an able research partner.

Contact:
US Sales Office :
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
E-Mail: sales@factmr.com

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates

Categories
Pharmaceutical

Demand For Lung Cancer Diagnostics Will Cultivate At A CAGR Of Around 7% During 2022-2032

The study on the Global Lung Cancer Diagnostics Market Insights published by Fact.MR is a comprehensive analysis of the key factors that are likely to determine the growth of Lung Cancer Diagnostics Market Insights in the upcoming years. Further, the study dives deep to investigate the micro and macro-economic parameters that are expected to influence the global scenario of the Lung Cancer Diagnostics Market Insights during the forecast period (2021-2031).

The report examines the current trends, growth opportunities, restraints, and market drivers that are projected to influence the overall dynamics of the Lung Cancer Diagnostics Market Insights in the assessment period.

Request Sample   https://www.factmr.com/connectus/sample?flag=S&rep_id=49 

 Lung Cancer Diagnostics Market Insights Segmentation

 By Region

  • North America
  • Europe
  • East Asia
  • South Asia
  • Latin America
  • Oceani
  • Middle East & Africa

By Test  Type

  • CA Test for Lung Cancer Diagnostics
  • HER2 Tests for Lung Cancer Diagnostics
  • ALK Tests for Lung Cancer Diagnostics
  • Angiogenesis Inhibitor for Lung Cancer Diagnostics
  • EGFR Mutation Tests for Lung Cancer Diagnostics
  • KRAS Mutation Tests for Lung Cancer Diagnostics
  • Others

Request Customization  https://www.factmr.com/connectus/sample?flag=RC&rep_id=49  

Essential Takeaways from the Lung Cancer Diagnostics Market Insights Report

  • Comparison of prominent players operating in the Lung Cancer Diagnostics Market Insights.
  • Recent developments and key strategies adopted by market players.
  • Study of the micro and macro-economic growth indicators.
  • Impact of the various factors on the value chain of the Lung Cancer Diagnostics Market Insights.
  • Growth opportunities for emerging market players in various regional markets.
  • Current trends influencing the scenario of the Lung Cancer Diagnostics Market Insights.

Request methodology https://www.factmr.com/connectus/sample?flag=RM&rep_id=49  

Important queries related to the Lung Cancer Diagnostics Market Insights addressed in the report:

  1. Who are the most prominent players in the Lung Cancer Diagnostics Market Insights?
  2. What are the factors that are likely to hinder the growth of the Lung Cancer Diagnostics Market Insights during the forecast period (2021-2031)?
  3. Why is the concentration of tier-1 companies high in specific region?
  4. How are the soaring prices of raw materials impacting the demand for keyword?
  5. Why are market players eyeing opportunities in particular region?

Buy Now https://www.factmr.com/checkout/49 

Why Choose Fact.MR

  • One of the most established market research companies in India
  • Round the clock customer support for clients across the globe
  • Tailor-made reports available without additional costs
  • Analysis of markets in over 150 countries
  • Data collected from credible primary and secondary sources

For More Insights- https://www.einpresswire.com/article/556697081/demand-for-light-duty-vehicles-wrap-films-is-surged-on-the-back-of-increasing-consumer-traction

About Fact.MR        

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. We have offices in US and Dublin, whereas our global headquarter is in Dubai. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Reach out to us with your goals, and we’ll be an able research partner.

Contact:                         

4-1-1 Nakano,
9F Nakano Sunplaza
Tokyo, 164-8512
Japan

Tel: +1 (888) 863-5616

                                                                                                                                            

Categories
Pharmaceutical

Demand for Lung Cancer Diagnostics CA Test Is Expected to Reach US$ 889.3 Mn by the End of 2022

Impact of Covid-19 on Healthcare Industry

With the pandemic plaguing maximum countries across the globe, healthcare industry is witnessing its fair share of ‘ups and downs’. The COVID-19 has placed an enormous strain on the healthcare sector’s workforce, facilities and infrastructure. Despite the endless pressure, healthcare sector is growing at a moderate pace due to the improvement in infrastructure and advancement in technology, healthcare sector is delivering a healthy performance.

According to a recent report by Fact.MR, the global demand for lung cancer diagnostics is anticipated to register 7.3% CAGR throughout the forecast period 2017 to 2022.

Growth of the global lung cancer diagnostics market is mainly attributed to surging developments in the lung cancer-specific biomarkers. Diagnostic tools, such as these, will facilitate personalized treatment approach for lung malignancies.

For More Insights Into The Market, Request a Sample of this Report – https://www.factmr.com/connectus/sample?flag=S&rep_id=49

Numerous biomarkers are in the research pipeline. Epigenomics AG has launched a new test which is based on blood by utilizing DNA methylation biomarkers, and their developments are in process. Initial results of these tests have guaranteed early diagnosis of lung cancer. These incidences are most likely to increase demand for diagnosis of lung cancer across the globe.

10 Key Takeaways from Fact.MR’s Report on the Global Lung Cancer Diagnostics Market

  1. North America is expected to remain dominant in the global lung cancer diagnostics market, with revenues expected to surpass US$ 1,000 Mn by 2022-end.
  2. Europe will continue to be the second most lucrative region for growth of the market, expanding at a high single-digit CAGR through 2022.
  3. CA tests will remain the largest adopted tests for diagnosis of lung cancer. Revenue from CA tests is expected to reach US$ 889.3 Mn by the end of 2022.
  4. Angiogenesis inhibitor tests will exhibit the fastest expansion in the global market for lung cancer diagnostics, followed by HER 2 tests. However, revenue from ALK tests to diagnose lung cancer is estimated to be low in the market throughout the forecast period.
  5. Hospital-associated labs are expected to remain the most lucrative among end-users in the global lung cancer diagnostics market.
  6. Cancer research institutes are expected to register the fastest growth in the global market for lung cancer diagnostics.
  7. Independent diagnostic laboratories are expected to be the second largest end-users of lung cancer diagnostics throughout the forecast period.
  8. Based on indication, even though non-small cell lung cancer will remain sought-after, small cell-lung cancer will exhibit the fastest growth through 2022. Non-small cell lung cancer will continue to account for the largest revenues during the forecast period.
  9. Revenue from small cell lung cancer will continue to be low in the global lung cancer diagnostics market.

Fact.MR’s report profiles key market players, which include

Illumina, Inc.
Abbott Laboratories
Thermo Fischer Scientific Inc.
QIAGEN N.V.
Quest Diagnostics Incorporated
NeoGenomics Laboratories, Inc.
NanoString Technologies, Inc.
Myriad Genetics, Inc.
Roche Holding AG
Danaher Corporation.

Share Your Requirements & Get Customized Reports – https://www.factmr.com/connectus/sample?flag=RC&rep_id=49

Global Lung Cancer Diagnostics Market: Segmentation

For clearer understanding of the Lung Cancer Diagnostics Market, analysts have segmented the market. The segmentation has been done on the basis of application, technology, and users. Each segment has been further explained with the help of graphs figures. This breakdown of the market gives the readers an objective view of the global Lung Cancer Diagnostics Market, which is essential to make sound investments.

Market Taxonomy

Test Type End User Indication
CA Test Hospital Associated Labs Non Small-cell Lung Cancer
HER2 Tests Independent Diagnostic Laboratories Small-cell Lung Cancer
ALK Tests Cancer Research Institutes
Angiogenesis Inhibitor Others
EGFR Mutation Tests
KRAS Mutation Tests
Others

A market research study is incomplete without regional analysis, and we are well aware of it. That is why, the report includes a comprehensive and all-inclusive study that solely concentrates on the geographical growth of the global Lung Cancer Diagnostics Market. The study also includes accurate estimations about market growth at the global, regional, and country levels. It empowers you to understand why some regional markets are flourishing while others are seeing a decline in growth. It also allows you to focus on geographies that hold the potential to create lucrative prospects in the near future.

Segmentation:

Test Type

  • CA Test for Lung Cancer Diagnostics
  • HER2 Tests for Lung Cancer Diagnostics
  • ALK Tests for Lung Cancer Diagnostics
  • Angiogenesis Inhibitor for Lung Cancer Diagnostics
  • EGFR Mutation Tests for Lung Cancer Diagnostics
  • KRAS Mutation Tests for Lung Cancer Diagnostics
  • Others

End-User

  • Lung Cancer Diagnostics  for Hospital Associated Labs
  • Lung Cancer Diagnostics for Independent Diagnostic Laboratories
  • Lung Cancer Diagnostics for Cancer Research Institutes
  • Others

Indication

  • Non-Small-cell Lung Cancer Diagnostics
  • Small-cell Lung Cancer Diagnostics

Following Questions Answers Covered in the Report are:

  • How will the global Lung Cancer Diagnostics Market perform during the forecast period? What will be the market size in terms of value and volume?
  • Which segment will drive the global Lung Cancer Diagnostics Market? Which regional market will show extensive growth in the future? What are the reasons?
  • How will the market dynamics change because of the impact of future market opportunities, restraints, and drivers?
  • What are the key strategies adopted by players to sustain themselves in the global Lung Cancer Diagnostics Market?
  • How will these strategies influence the market growth and competition?

Access Research Methodology Prepared By Experts – https://www.factmr.com/connectus/sample?flag=RM&rep_id=49

Regional analysis includes

  • North America (U.S., Canada)
  • Latin America (Brazil, Mexico, Argentina, Chile, Peru, Rest of LATAM)
  • EU – (Germany, France, Italy, Spain), UK, BENELUX (Belgium, Netherlands, Luxemburg), NORDIC (Norway, Denmark, Iceland, Sweden), Eastern Europe (Poland, Ukraine, Czech Rep. etc.), Rest of Europe
  • CIS & Russia
  • Japan
  • Asia Pacific Excluding Japan (Greater China, India, S. Korea, ASEAN Countries, Rest of APEJ)
  • Middle East and Africa (GCC Countries, Turkey, Iran, Israel, South Africa , Rest of MEA)

 

Get More Insights –http://www.globenewswire.com/en/news-release/2020/03/17/2001947/0/en/Sales-of-Automotive-Wrap-Films-to-Expand-6X-Between-2019-and-2029-MEA-Poised-to-Turn-Highly-Lucrative-Forecasts-a-New-Fact-MR-Report.html

 

The Report Covers Exhaustive Analysis On:

  • Market Segments
  • Market Dynamics
  • Market Size & Demand
  • Current Trends/Issues/Challenges
  • Competition & Companies involved
  • Technology
  • Value Chain

The Lung Cancer Diagnostics Market report answers the following queries:

  1. What is the largest share held by key players in the market?
  2. What strategies have proven most advantageous in the Lung Cancer Diagnostics Market?
  3. Which region promises largest opportunity for new investors during the forecast period 2021 to 2031?
  4. What factors will most likely present challenges to growth during the forecast period?
  5. What will be the value of total revenues, and at what CAGR will the growth compound during the forecast period 2021 to 2031?

About Us:

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.

Contact:

US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
Email: sales@factmr.com
Visit Our Website: https://www.factmr.com